• Facilities
    • Cork, Ireland
    • Cramlington, UK
    • Deeside, UK
    • Newcastle Biosphere, UK
    • North Carolina, US
    • Wisconsin, US
  • Sustainability
    • Environmental sustainability
  • Molecule Lifecycle
    • Discovery
    • Preclinical
    • Phase One
    • Phase Two
    • Phase Three
    • Launch
  • About Us
    • Our Heritage
    • Vision and Values
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Meet our People
    • Our Locations
  • News and Events
    • News
    • Events
  • Contact
Sterling Pharma Solutions Logo
Sterling Pharma Solutions Logo
✕
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Benchâ„¢
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
  • Knowledge Hub
  • Home
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Benchâ„¢
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
  • Molecule Lifecycle
  • Knowledge Hub
  • About Us
    • Our Heritage
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Facilities
  • Sustainability
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Vision and Values
    • Meet our People
    • Our Locations
  • News and Events
  • Contact
Home - Knowledge Hub - Drug Discovery - Setting the foundation for success: Streamlining early phase API discovery and development

Setting the foundation for success: Streamlining early phase API discovery and development

Webinar1 min read 01st Feb 2022
Share via email Share via LinkedIn

Authored by

Mathew Minardi - EVP of Global Project Management

Mathew Minardi

PhD, BS | EVP of Global Project Management

Image from early phase API discovery and development at Sterling animation showing scientists at work

Animation

Early phase API discovery and development

View more
Cary carousel

Article

Sterling Pharma Solutions expands early phase development capabilities at Cary

View more
Scientist in labs at Sterling performing early phase development work

Article

Top 10 early phase considerations

View more

Authored by

Mathew Minardi - EVP of Global Project Management

Mathew Minardi

PhD, BS | EVP of Global Project Management

Share via email Share via LinkedIn

Popular articles

Scientist at one of Sterling's global CDMO facilities working in lab
Infographic1 min read
Cross-site collaboration in action Read more
Solid state chemistry
Blog10 min read
The top 3 challenges in solid state chemistry and how to overcome them Read more
API Manufacturing
Infographic1 min read
De-risking hydrogenation Read more
Analytical Services
Webinar32 min read
Quality from the start: A deep dive into analytical method development Read more
Video2 min read
Facility overview video: Newcastle Biosphere, UK Read more
Blog6 min read
Operational excellence: The key factors contributing towards success Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

This field is for validation purposes and should be left unchanged.
Name(Required)
This field is hidden when viewing the form
Please click here for our privacy policy
Sterling Pharma Solutions Footer LogoService. Passion. Science.
linkedin iconfacebook iconyoutube icon
Enquire now
  • Privacy Policy
  • Cookie Policy
  • Manage Cookies
  • Website Terms and Conditions
  • Gender Pay Gap
  • Modern Slavery Policy

PDMO® is registered in the U.S. Patent and Trademark Office.

PDMO® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.